148 related articles for article (PubMed ID: 33086869)
1. HDL (High-Density Lipoprotein) and ApoA-1 (Apolipoprotein A-1) Potentially Modulate Pancreatic α-Cell Glucagon Secretion.
Mancuso E; Mannino GC; Fuoco A; Leo A; Citraro R; Averta C; Spiga R; Russo E; De Sarro G; Andreozzi F; Sesti G
Arterioscler Thromb Vasc Biol; 2020 Dec; 40(12):2941-2952. PubMed ID: 33086869
[TBL] [Abstract][Full Text] [Related]
2. HDL-apoA-I induces the expression of angiopoietin like 4 (ANGPTL4) in endothelial cells via a PI3K/AKT/FOXO1 signaling pathway.
Theofilatos D; Fotakis P; Valanti E; Sanoudou D; Zannis V; Kardassis D
Metabolism; 2018 Oct; 87():36-47. PubMed ID: 29928895
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein A-I increases insulin secretion and production from pancreatic β-cells via a G-protein-cAMP-PKA-FoxO1-dependent mechanism.
Cochran BJ; Bisoendial RJ; Hou L; Glaros EN; Rossy J; Thomas SR; Barter PJ; Rye KA
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2261-7. PubMed ID: 25147338
[TBL] [Abstract][Full Text] [Related]
4. HDL protects against doxorubicin-induced cardiotoxicity in a scavenger receptor class B type 1-, PI3K-, and Akt-dependent manner.
Durham KK; Chathely KM; Mak KC; Momen A; Thomas CT; Zhao YY; MacDonald ME; Curtis JM; Husain M; Trigatti BL
Am J Physiol Heart Circ Physiol; 2018 Jan; 314(1):H31-H44. PubMed ID: 28986362
[TBL] [Abstract][Full Text] [Related]
5. ApoA-I/SR-BI modulates S1P/S1PR2-mediated inflammation through the PI3K/Akt signaling pathway in HUVECs.
Ren K; Lu YJ; Mo ZC; -Liu X; Tang ZL; Jiang Y; Peng XS; Li L; Zhang QH; Yi GH
J Physiol Biochem; 2017 May; 73(2):287-296. PubMed ID: 28181168
[TBL] [Abstract][Full Text] [Related]
6. Evidence of the receptor-mediated influence of melatonin on pancreatic glucagon secretion via the Gαq protein-coupled and PI3K signaling pathways.
Bähr I; Mühlbauer E; Albrecht E; Peschke E
J Pineal Res; 2012 Nov; 53(4):390-8. PubMed ID: 22672634
[TBL] [Abstract][Full Text] [Related]
7. Palmitate affects insulin receptor phosphorylation and intracellular insulin signal in a pancreatic alpha-cell line.
Piro S; Maniscalchi ET; Monello A; Pandini G; Mascali LG; Rabuazzo AM; Purrello F
Endocrinology; 2010 Sep; 151(9):4197-206. PubMed ID: 20573722
[TBL] [Abstract][Full Text] [Related]
8. Insulin regulates glucagon-like peptide-1 secretion by pancreatic alpha cells.
Liu P; Song J; Liu H; Yan F; He T; Wang L; Shen H; Hou X; Chen L
Endocrine; 2018 Nov; 62(2):394-403. PubMed ID: 30084102
[TBL] [Abstract][Full Text] [Related]
9. Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion.
Fryirs MA; Barter PJ; Appavoo M; Tuch BE; Tabet F; Heather AK; Rye KA
Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1642-8. PubMed ID: 20466975
[TBL] [Abstract][Full Text] [Related]
10. Glucotoxicity and α cell dysfunction: involvement of the PI3K/Akt pathway in glucose-induced insulin resistance in rat islets and clonal αTC1-6 cells.
Shen XX; Li HL; Pan L; Hong J; Xiao J; Hermansen K; Jeppesen PB; Li GW
Endocr Res; 2012; 37(1):12-24. PubMed ID: 22007944
[TBL] [Abstract][Full Text] [Related]
11. A New Way for Beta Cell Neogenesis: Transdifferentiation from Alpha Cells Induced by Glucagon-Like Peptide 1.
Zhang Z; Hu Y; Xu N; Zhou W; Yang L; Chen R; Yang R; Sun J; Chen H
J Diabetes Res; 2019; 2019():2583047. PubMed ID: 31001561
[TBL] [Abstract][Full Text] [Related]
12. Comparison of pancreatic beta cells and alpha cells under hyperglycemia: Inverse coupling in pAkt-FoxO1.
Kim MK; Shin HM; Jung H; Lee E; Kim TK; Kim TN; Kwon MJ; Lee SH; Rhee BD; Park JH
Diabetes Res Clin Pract; 2017 Sep; 131():1-11. PubMed ID: 28666105
[TBL] [Abstract][Full Text] [Related]
13. Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells.
Rütti S; Ehses JA; Sibler RA; Prazak R; Rohrer L; Georgopoulos S; Meier DT; Niclauss N; Berney T; Donath MY; von Eckardstein A
Endocrinology; 2009 Oct; 150(10):4521-30. PubMed ID: 19628574
[TBL] [Abstract][Full Text] [Related]
14. In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance.
Pietzsch J; Julius U; Nitzsche S; Hanefeld M
Diabetes; 1998 Dec; 47(12):1928-34. PubMed ID: 9836526
[TBL] [Abstract][Full Text] [Related]
15. High-density lipoprotein apolipoprotein A-I kinetics in obesity.
Ooi EM; Watts GF; Farvid MS; Chan DC; Allen MC; Zilko SR; Barrett PH
Obes Res; 2005 Jun; 13(6):1008-16. PubMed ID: 15976143
[TBL] [Abstract][Full Text] [Related]
16. An involvement of SR-B1 mediated PI3K-Akt-eNOS signaling in HDL-induced cyclooxygenase 2 expression and prostacyclin production in endothelial cells.
Zhang QH; Zu XY; Cao RX; Liu JH; Mo ZC; Zeng Y; Li YB; Xiong SL; Liu X; Liao DF; Yi GH
Biochem Biophys Res Commun; 2012 Mar; 420(1):17-23. PubMed ID: 22390933
[TBL] [Abstract][Full Text] [Related]
17. Roles of high apolipoprotein E blood levels and HDL in development of familial dysbetalipoproteinemia in ε2ε2 subjects.
Corsetti JP; Sparks CE; Bakker SJL; Gruppen EG; Dullaart RPF
Clin Biochem; 2018 Feb; 52():67-72. PubMed ID: 29157655
[TBL] [Abstract][Full Text] [Related]
18. HDL-C and HDL-C/ApoA-I predict long-term progression of glycemia in established type 2 diabetes.
Waldman B; Jenkins AJ; Davis TM; Taskinen MR; Scott R; O'Connell RL; Gebski VJ; Ng MK; Keech AC;
Diabetes Care; 2014 Aug; 37(8):2351-8. PubMed ID: 24804699
[TBL] [Abstract][Full Text] [Related]
19. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.
Rajkhowa M; Neary RH; Kumpatla P; Game FL; Jones PW; Obhrai MS; Clayton RN
J Clin Endocrinol Metab; 1997 Oct; 82(10):3389-94. PubMed ID: 9329374
[TBL] [Abstract][Full Text] [Related]
20. Phosphoproteins regulated by the interaction of high-density lipoprotein with human skin fibroblasts.
Garver WS; Deeg MA; Bowen RF; Culala MM; Bierman EL; Oram JF
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2698-706. PubMed ID: 9409245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
